PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CHINA STAR ENT (0326.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

BMG8437G3195

Sector

Communication Services

IPO Date

Nov 12, 1992

Highlights

Market Cap

HK$1.14B

Total Revenue (TTM)

HK$193.32M

Gross Profit (TTM)

HK$57.85M

EBITDA (TTM)

-HK$51.57M

Year Range

HK$0.39 - HK$0.88

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in CHINA STAR ENT, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-16.67%
9.07%
0326.HK (CHINA STAR ENT)
Benchmark (^GSPC)

Returns By Period

CHINA STAR ENT had a return of 0.00% year-to-date (YTD) and -39.02% in the last 12 months. Over the past 10 years, CHINA STAR ENT had an annualized return of -14.37%, while the S&P 500 had an annualized return of 11.31%, indicating that CHINA STAR ENT did not perform as well as the benchmark.


0326.HK

YTD

0.00%

1M

16.28%

6M

-16.67%

1Y

-39.02%

5Y*

-22.69%

10Y*

-14.37%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of 0326.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-18.00%0.00%
2024-1.25%0.00%-21.52%25.81%-7.69%-13.89%-19.35%24.00%0.00%-9.68%0.00%-10.71%-37.50%
202314.86%-8.24%-17.95%23.44%-1.27%2.56%-0.00%12.50%-8.89%-2.44%2.50%-2.44%8.11%
20226.02%2.27%-5.56%-2.35%1.20%1.19%-5.88%0.00%0.00%-5.00%-1.32%-1.33%-10.84%
2021-4.70%-3.52%3.65%0.70%-10.49%-0.78%-12.60%-7.21%-11.65%17.58%-11.21%-12.63%-44.30%
20202.00%-0.65%7.24%7.36%-0.00%-2.86%-4.12%-0.00%-11.04%6.90%-3.87%0.00%-0.67%
2019-15.59%4.99%-7.94%0.00%39.67%1.23%6.10%-8.05%27.49%-4.36%36.90%30.43%145.06%
201813.14%-8.94%-7.83%-29.79%-1.53%-13.85%3.88%77.74%10.42%16.98%38.72%1.16%89.27%
2017-4.27%5.54%-24.20%-5.57%-4.41%56.95%1.95%5.77%3.65%10.53%-9.52%-13.16%5.31%
2016-20.51%0.00%-4.84%20.34%1.40%-5.55%8.82%-18.92%-5.00%3.52%-3.40%-17.53%-39.74%
2015-8.15%3.23%-4.69%1.64%4.03%-7.75%-32.77%-28.75%-47.37%20.00%-15.56%2.64%-76.89%
201412.60%37.31%-20.11%-13.61%-3.93%-3.28%1.70%0.83%-4.96%1.74%19.66%-3.57%13.44%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 0326.HK is 16, meaning it’s performing worse than 84% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of 0326.HK is 1616
Overall Rank
The Sharpe Ratio Rank of 0326.HK is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of 0326.HK is 1515
Sortino Ratio Rank
The Omega Ratio Rank of 0326.HK is 1515
Omega Ratio Rank
The Calmar Ratio Rank of 0326.HK is 2222
Calmar Ratio Rank
The Martin Ratio Rank of 0326.HK is 1313
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for CHINA STAR ENT (0326.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for 0326.HK, currently valued at -0.61, compared to the broader market-2.000.002.00-0.611.74
The chart of Sortino ratio for 0326.HK, currently valued at -0.73, compared to the broader market-4.00-2.000.002.004.006.00-0.732.35
The chart of Omega ratio for 0326.HK, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.32
The chart of Calmar ratio for 0326.HK, currently valued at -0.40, compared to the broader market0.002.004.006.00-0.402.61
The chart of Martin ratio for 0326.HK, currently valued at -1.24, compared to the broader market0.0010.0020.0030.00-1.2410.66
0326.HK
^GSPC

The current CHINA STAR ENT Sharpe ratio is -0.61. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of CHINA STAR ENT with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.61
1.68
0326.HK (CHINA STAR ENT)
Benchmark (^GSPC)

Dividends

Dividend History

CHINA STAR ENT provided a 0.00% dividend yield over the last twelve months, with an annual payout of HK$0.00 per share.


0.00%5.00%10.00%15.00%20.00%HK$0.00HK$0.05HK$0.10HK$0.15HK$0.20HK$0.25201920202021202220232024
Dividends
Dividend Yield
PeriodTTM202420232022202120202019
DividendHK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.28

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%18.33%

Monthly Dividends

The table displays the monthly dividend distributions for CHINA STAR ENT. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025HK$0.00HK$0.00HK$0.00
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.15HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.13HK$0.00HK$0.00HK$0.28

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.98%
0
0326.HK (CHINA STAR ENT)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the CHINA STAR ENT. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CHINA STAR ENT was 99.99%, occurring on Jul 18, 2018. The portfolio has not yet recovered.

The current CHINA STAR ENT drawdown is 99.98%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.99%Feb 11, 20043351Jul 18, 2018
-39.68%Sep 13, 200295Feb 4, 200315Feb 25, 2003110
-31.82%Mar 3, 200338Apr 30, 200355Jul 24, 200393
-14.29%Oct 2, 200351Dec 11, 200320Jan 13, 200471
-11.9%Sep 4, 20035Sep 10, 200313Sep 30, 200318

Volatility

Volatility Chart

The current CHINA STAR ENT volatility is 27.20%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
27.20%
3.03%
0326.HK (CHINA STAR ENT)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of CHINA STAR ENT over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for CHINA STAR ENT.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab